Kexi Wang

824 total citations
32 papers, 594 citations indexed

About

Kexi Wang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Kexi Wang has authored 32 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 10 papers in Molecular Biology and 8 papers in Surgery. Recurrent topics in Kexi Wang's work include Esophageal Cancer Research and Treatment (7 papers), Esophageal and GI Pathology (6 papers) and Microtubule and mitosis dynamics (5 papers). Kexi Wang is often cited by papers focused on Esophageal Cancer Research and Treatment (7 papers), Esophageal and GI Pathology (6 papers) and Microtubule and mitosis dynamics (5 papers). Kexi Wang collaborates with scholars based in China, United States and Israel. Kexi Wang's co-authors include Song‐Tao Liu, Tim J. Yen, Aaron R. Tipton, Dawn Macdonald, Gordon K. Chan, James C. Hittle, Shirly Miniowitz-Shemtov, Danielle Sitry-Shevah, Sharon Kaisari and Avram Hershko and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Kexi Wang

28 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kexi Wang China 11 376 246 75 50 47 32 594
Li Teng China 18 699 1.9× 137 0.6× 30 0.4× 67 1.3× 191 4.1× 44 1.0k
Lihua Xu China 10 440 1.2× 117 0.5× 112 1.5× 33 0.7× 84 1.8× 36 873
Shubham Tripathi United States 11 406 1.1× 95 0.4× 315 4.2× 62 1.2× 225 4.8× 31 699
Keita Tsuji Japan 15 168 0.4× 19 0.1× 70 0.9× 103 2.1× 51 1.1× 82 719
Marjan Yaghmaie Iran 15 384 1.0× 38 0.2× 118 1.6× 61 1.2× 210 4.5× 64 705
Sunghak Kim South Korea 8 299 0.8× 30 0.1× 48 0.6× 39 0.8× 221 4.7× 25 611
Quân Tran United States 7 284 0.8× 85 0.3× 28 0.4× 16 0.3× 70 1.5× 12 566
Mohamed A. Elmonem Egypt 18 393 1.0× 86 0.3× 47 0.6× 143 2.9× 27 0.6× 53 1.2k
Xinquan Ge China 6 279 0.7× 83 0.3× 80 1.1× 10 0.2× 27 0.6× 17 451

Countries citing papers authored by Kexi Wang

Since Specialization
Citations

This map shows the geographic impact of Kexi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kexi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kexi Wang more than expected).

Fields of papers citing papers by Kexi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kexi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kexi Wang. The network helps show where Kexi Wang may publish in the future.

Co-authorship network of co-authors of Kexi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Kexi Wang. A scholar is included among the top collaborators of Kexi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kexi Wang. Kexi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lei, Kai, Jing Huang, Kefeng Wang, et al.. (2025). Single-cell analysis reveals transcriptomic features and therapeutic targets in primary pulmonary lymphoepithelioma-like carcinoma. Communications Biology. 8(1). 394–394.
2.
Lei, Kai, Nan Lü, Jing Huang, et al.. (2024). CircPDE5A-encoded novel regulator of the PI3K/AKT pathway inhibits esophageal squamous cell carcinoma progression by promoting USP14-mediated de-ubiquitination of PIK3IP1. Journal of Experimental & Clinical Cancer Research. 43(1). 124–124. 16 indexed citations
3.
Wang, Kexi, Jing Huang, Xuan Xie, et al.. (2023). A propensity score–matched analysis of neoadjuvant chemoimmunotherapy versus surgery alone for locally advanced esophageal squamous cell carcinoma. Journal of Surgical Oncology. 128(2). 207–217. 6 indexed citations
4.
Lei, Kai, Lin Li, Kexi Wang, et al.. (2023). Effects of Lipid Metabolism-Related Genes PTGIS and HRASLS on Phenotype, Prognosis, and Tumor Immunity in Lung Squamous Cell Carcinoma. Oxidative Medicine and Cellular Longevity. 2023. 1–31. 7 indexed citations
5.
Wang, Kexi, Xiaotian He, Duoguang Wu, et al.. (2023). The comparison of manual and mechanical anastomosis after total pharyngolaryngoesophagectomy. Frontiers in Oncology. 13. 1041396–1041396. 1 indexed citations
6.
Zhang, Shuishen, Junying Chen, Bin Li, et al.. (2022). Family history of cancer is a prognostic factor for better survival in operable esophageal squamous cell carcinoma: A propensity score matching analysis. Frontiers in Oncology. 12. 945937–945937. 2 indexed citations
8.
Zhong, Jian, et al.. (2021). Prognostic impact of sterilized lymph nodes in esophageal squamous cell carcinomas after neoadjuvant chemoradiotherapy. European Journal of Surgical Oncology. 47(12). 3074–3080. 4 indexed citations
9.
Wang, Kexi, Jian Zhong, Qianwen Liu, Peng Lin, & Jianhua Fu. (2021). A Propensity Score–Matched Analysis of Thoracolaparoscopic vs Open McKeown’s Esophagectomy. The Annals of Thoracic Surgery. 113(2). 473–481. 7 indexed citations
10.
Jin, Ke, Kexi Wang, Huizhong Zhang, et al.. (2018). Solitary Pulmonary Lesion in Patients with History of Malignancy: Primary Lung Cancer or Metastatic Cancer?. Annals of Surgical Oncology. 25(5). 1237–1244. 7 indexed citations
11.
Eytan, Esther, Kexi Wang, Shirly Miniowitz-Shemtov, et al.. (2014). Disassembly of mitotic checkpoint complexes by the joint action of the AAA-ATPase TRIP13 and p31 comet. Proceedings of the National Academy of Sciences. 111(33). 12019–12024. 96 indexed citations
12.
Wang, Kexi, James C. Hittle, Dawn Macdonald, et al.. (2014). Thyroid Hormone Receptor Interacting Protein 13 (TRIP13) AAA-ATPase Is a Novel Mitotic Checkpoint-silencing Protein. Journal of Biological Chemistry. 289(34). 23928–23937. 113 indexed citations
13.
Wang, Kexi. (2014). Detection of dust mite allergens from filters of air conditioners. Zhongguo meijie shengwuxue ji kongzhi zazhi. 1 indexed citations
14.
Wang, Kexi. (2013). Research on the Model,Pattern and Pattern Selection of Contract Governance in Family Business Based on Agency and Stewardship Theory. Journal of Business Economics.
15.
Tipton, Aaron R., Wenbin Ji, Michael E. Bekier, et al.. (2013). Monopolar Spindle 1 (MPS1) Kinase Promotes Production of Closed MAD2 (C-MAD2) Conformer and Assembly of the Mitotic Checkpoint Complex. Journal of Biological Chemistry. 288(49). 35149–35158. 46 indexed citations
16.
Tipton, Aaron R., et al.. (2012). Identification of novel mitosis regulators through data mining with human centromere/kinetochore proteins as group queries. BMC Cell Biology. 13(1). 15–15. 44 indexed citations
17.
Chen, Weimin, et al.. (2012). A Three-stage Data Mining Model for Reject Inference. 34–38. 3 indexed citations
18.
Tipton, Aaron R., Kexi Wang, Laura A. Link, et al.. (2011). BUBR1 and Closed MAD2 (C-MAD2) Interact Directly to Assemble a Functional Mitotic Checkpoint Complex. Journal of Biological Chemistry. 286(24). 21173–21179. 46 indexed citations
19.
Wang, Kexi. (2009). Finite Element Analysis on Ultra Large Drum of Belt Conveyor. Coal science and technology. 1 indexed citations
20.
Wang, Kexi. (2006). Investigation on intermediate host infection of clonorchis sinensis in Huainan area. Chinese Journal of Public Health. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026